Antileukemic drug

Antileukemic drug

Antileukemic drugs (pronunciation: an-ti-loo-kee-mik drugs) are a class of pharmacological agents used in the treatment of leukemia, a type of cancer that affects the blood and bone marrow.

Etymology

The term "antileukemic" is derived from the Greek words "anti" meaning against, and "leukos" meaning white, referring to the white blood cells that are abnormally increased in leukemia. The term "drug" comes from the Old French "drogue", possibly derived from the Dutch word "droog" (meaning "dry"), as herbs, powders, and medications were often dried for use.

Usage

Antileukemic drugs work by killing or stopping the growth of cancer cells. They are used in chemotherapy regimens to treat various types of leukemia, including Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia (CML).

Types of Antileukemic Drugs

There are several types of antileukemic drugs, including:

• Cytarabine
• Daunorubicin
• Imatinib
• Nilotinib
• Dasatinib

Each of these drugs works in a different way to stop the growth of cancer cells.

Related Terms

• Chemotherapy
• Leukemia
• Cancer
• Pharmacology
• Cytarabine
• Daunorubicin
• Imatinib
• Nilotinib
• Dasatinib

External links

• Medical encyclopedia article on Antileukemic drug
• Wikipedia's article - Antileukemic drug

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski